Treatment of early hypertensive renal damage with Quanduzhong capsules: two case reports
This case report shows that Quanduzhong capsule can lower blood pressure and improve symptoms of microalbuminuria and proteinuria in patients with early hypertensive renal damage, and may provide a promising treatment option for the management of early hypertensive renal damage. However, the evidence is preliminary and larger, controlled studies are needed to determine its efficacy and potential advantages.
Authors
- Zhigang Zhou (ORCID: https://orcid.org/0000-0001-6159-7793)
- Gaoyu Zhang (ORCID: https://orcid.org/0000-0003-1809-2807)
- Xuefei Gao (ORCID: https://orcid.org/0000-0001-9245-9035)
- Qing He (ORCID: https://orcid.org/0000-0003-2596-4984)
- Xiaofeng Li (ORCID: https://orcid.org/0009-0005-3765-0124)
- Zihan Wang (ORCID: https://orcid.org/0000-0003-4588-480X)
- Yu Cui (ORCID: https://orcid.org/0000-0002-3480-0730)
- Lin Li (ORCID: https://orcid.org/0000-0002-3659-7529)
- Jia-Rong Fan
Institutions
- Beijing University of Chinese Medicine (CN)
- China-Japan Friendship Hospital (CN)
Publication Details
- Journal
- Journal of Hypertension
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1097/hjh.0000000000003966
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00